Corcept Therapeutics (CORT) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $79.71 -0.25%
EPS Growth %: -96.6%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
JFIN, KEQU, LASE, More
EPS Growth %: -96.6%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q4 EPS of $0.24, $0.01 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $87.9 million versus the consensus estimate of $87.67 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
